An update on the management of bleeding disorders during pregnancy

Current Opinion in Hematology

Volumn 22, Issue 5, 2015, Pages 397-405

  Kouides, Peter A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Bleeding disorders; Postpartum hemorrhage; Pregnancy; Thrombocytopathy; Von Willebrand disease

Indexed keywords

ANTIFIBRINOLYTIC AGENT; DESMOPRESSIN; TRANEXAMIC ACID; BLOOD CLOTTING FACTOR;

BLEEDING DISORDER; DRUG TOLERABILITY; FEMALE; HEMOPHILIA; HUMAN; MORBIDITY; MORTALITY; POSTPARTUM HEMORRHAGE; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SUBSTITUTION THERAPY; VON WILLEBRAND DISEASE; BLOOD COAGULATION DISORDERS; HEMORRHAGIC DISORDERS;

ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; FEMALE; HEMORRHAGIC DISORDERS; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; TRANEXAMIC ACID;

EID: 84942801193     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000167     Document Type: Review

References (34)

1. Clark P, Brennand J, Conkie JA, et al. Activated proteinC sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998; 79: 1166-1170.
2. Szecsi PB, Jorgensen M, Klajnbard A, et al. Haemostatic reference intervals in pregnancy. Thromb Haemost 2010; 103: 718-727.
3. Huq FY, Kulkarni A, Agbim EC, et al. Changes in the levels of factor VIII and von Willebrand factor in the puerperium. Haemophilia 2012; 18: 241-245.
4. James AH, Konkle BA, Kouides P, et al. Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis. Haemophilia 2015; 21: 81-87.
5. Biguzzi E, Franchi F, Acaia B, et al. Genetic background and risk of postpartum haemorrhage: Results from an Italian cohort of 3219 women. Haemophilia 2014; 20: E377-e383.
6. Kadir RA, Lee CA, Sabin CA, et al. Pregnancy in women with von Willebrands disease or Factor XI deficiency. Br J Obstetr Gynaecol 1998; 105: 314-321.
7. Kouides PA, Burkhart P, Phatak P, et al. Gynecological and obstetrical morbidity in women with type I Von Willebrand disease: Results of a patient survey. Haemophilia 2000; 6: 643-648.
8. Greer IA, Lowe GD, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Brit J Obstetr Gynaecol 1991; 98: 909-918.
9. de Wee EM, Knol HM, Mauser-Bunschoten EP, et al. Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease. Thromb Haemost 2011; 106: 885-892.
10. Shahbazi S, Moghaddam-Banaem L, Ekhtesari F, Ala FA. Impact of inherited bleeding disorders on pregnancy and postpartum hemorrhage. Blood Coagul Fibrinolysis 2012; 23: 603-607.
11. James AH, Jamison MG. Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease. J Thromb Haemost 2007; 5: 1165-1169.
12. Chee YL, Townend J, Crowther M, et al. Assessment of von Willebrand disease as a risk factor for primary postpartum haemorrhage. Haemophilia 2012; 18: 593-597.
13. Davies J, Kadir RA. Reply to von Willebrand's disease and postpartum haemorrhage by Chee et al. Haemophilia 2012; 18: E399-e400.
14. CastamanG, Tosetto A, Rodeghiero F. Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutations. Haematologica 2010; 95: 963-969.
15. Trigg DE, Stergiotou I, Peitsidis P, Kadir RA. A systematic review: The use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. Haemophilia 2012; 18: 25-33.
16. Sharma R, Stein D. Hyponatremia after desmopressin (DDAVP) use in pediatric patients with bleeding disorders undergoing surgeries. J Pediatr Hematol Oncol 2014; 36: E371-e375.
17. Demers C, Derzko C, David M, Douglas J. Gynaecological and obstetric management of women with inherited bleeding disorders. J Obstet Gynaecol Can 2005; 27: 707-732.
18. Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD) : Evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) 1. Haemophilia 2008; 14: 171-232.
19. Mannucci PM, Franchini M, Castaman G, Federici AB. Evidence-based recommendations on the treatment of von Willebrand disease in Italy. Blood Transfus 2009; 7: 117-126.
20. Laffan MA, Lester W, O'Donnell JS, et al. The diagnosis and management of von Willebrand disease: A United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br J Haematol 2014; 167: 453-465.
21. Sanchez-Luceros A, Meschengieser SS, Marchese C, et al. Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium. Blood Coagul Fibrinolysis 2003; 14: 647-651.
22. Stoof CM, van Steenbergen HW, Zwagemaker A, et al. Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: A retrospective study. Haemophilia 2015. [Epub ahead of print]
23. Plug I, Mauser-Bunschoten EP, Brocker-Vriends AH, et al. Bleeding in carriers of hemophilia. Blood 2006; 108: 52-56.
24. Paroskie A, Gailani D, Debaun MR, Sidonio RF Jr. A cross-sectional study of bleeding phenotype in haemophilia A carriers. Br J Haematol 2015. [Epub ahead of print]
25. Gilbert L, Rollins L, Hilmes M, et al. Haemophilia A carriers demonstrate pathological and radiological evidence of structural joint changes. Haemophilia 2014; 20: E426-e429.
26. Gilbert L, Paroskie A, Galiani DDM, Sidonio RF. Hemophilia A carriers experience reduced health-related quality of life. Haemophilia 2015. [Epub ahead of print]
27. Sentilhes L, Lasocki S, Ducloy-Bouthors AS, et al. Tranexamic acid for the prevention and treatment of postpartum haemorrhage. Br J Anaesth 2015; 114: 579-587.
28. Abdul-Kadir R, McLintock C, Ducloy AS, et al. Evaluation and management of postpartum hemorrhage: Consensus from an international expert panel. Transfusion 2014; 54: 1756-1768.
29. Sharma V, Khalid A, Cohen AJ. Management of pregnancy in a patient with severe hemophilia type a. AJP Rep 2013; 3: 29-32.
30. Tengborn L, Blomback M, Berntorp E. Tranexamic acid: An old drug still going strong and making a revival. Thromb Res 2015; 135: 231-242.
31. Kadir RA, Davies J, Winikoff R, et al. Pregnancy complications and obstetric care in women with inherited bleeding disorders. Haemophilia 2013; 19 (Suppl 4) : 1-10.
32. Ducloy-Bouthors AS, Jude B, Duhamel A, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 2011; 15: R117.
33. Shakur H, Elbourne D, Gulmezoglu M, et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial) : Tranexamic acid for the treatment of postpartum haemorrhage: An international randomised, double blind placebo controlled trial. Trials 2010; 11: 40.
34. Mumford AD, Ackroyd S, Alikhan R, et al. Guideline for the diagnosis and management of the rare coagulation disorders: A United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol 2014; 167: 304-326.